ArticleFrontiers in oncology2023

IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center.

Thomas Le Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.